7-148259641-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.3382-7392A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 152,118 control chromosomes in the GnomAD database, including 9,752 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 9752 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.07

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.3382-7392A>G
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.3382-7392A>G
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000628930.2
TSL:2
c.559-7392A>G
intron
N/AENSP00000487516.1
CNTNAP2
ENST00000627772.2
TSL:2
n.1555-7392A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.354
AC:
53777
AN:
152000
Hom.:
9730
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.340
Gnomad AMI
AF:
0.289
Gnomad AMR
AF:
0.358
Gnomad ASJ
AF:
0.461
Gnomad EAS
AF:
0.214
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.418
Gnomad MID
AF:
0.434
Gnomad NFE
AF:
0.364
Gnomad OTH
AF:
0.389
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.354
AC:
53827
AN:
152118
Hom.:
9752
Cov.:
32
AF XY:
0.352
AC XY:
26165
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.341
AC:
14136
AN:
41498
American (AMR)
AF:
0.358
AC:
5476
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.461
AC:
1598
AN:
3468
East Asian (EAS)
AF:
0.213
AC:
1101
AN:
5168
South Asian (SAS)
AF:
0.239
AC:
1153
AN:
4820
European-Finnish (FIN)
AF:
0.418
AC:
4420
AN:
10578
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.364
AC:
24740
AN:
67982
Other (OTH)
AF:
0.385
AC:
813
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1774
3548
5321
7095
8869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.363
Hom.:
6425
Bravo
AF:
0.352
Asia WGS
AF:
0.258
AC:
899
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.040
DANN
Benign
0.29
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11980146; hg19: chr7-147956733; API